序号 | 专利名 | 申请号 | 申请日 | 公开(公告)号 | 公开(公告)日 | 发明人 |
---|---|---|---|---|---|---|
41 | HYDROPHILIC POLYETHER AMINE SOLUTION AND USES THEREOF | PCT/US2022027779 | 2022-05-05 | WO2022235871A1 | 2022-11-10 | ZHAO HAIBO |
Systems Solutions and methods for cleaning the air intake valve of a GDI engine during engine operation with a PEA-water solution injection. | ||||||
42 | 液晶表示素子及びその製造方法 | PCT/JP2016/061794 | 2016-04-12 | WO2017134841A1 | 2017-08-10 | 林 正直; 清水 健太; 楠本 哲生; 桑名 康弘 |
本発明は、誘電率異方性、粘度、ネマチック相上限温度、回転粘度(γ1)等の液晶表示素子としての諸特性及び液晶表示素子の焼き付き特性を悪化させることなく、製造時の滴下痕が発生し難く、液晶表示素子としての諸特性が向上した、高い信頼性を有する液晶表示素子及びその製造方法を提供する。また、本発明によれば、液晶表示素子としての高速応答性優れ、焼き付きの発生が少なく、その製造時における滴下痕の発生が少なく、液晶表示素子としての諸特性に優れ、また、信頼性が高いため、液晶TV、モニター等の表示素子として有効に用いることができる。また、本発明によれば、滴下痕の発生し難い効率的な液晶表示素子の製造が可能となる。 |
||||||
43 | SUBSTITUTED PHENETHYLAMINES | PCT/US2008/065627 | 2008-06-03 | WO2008151179A2 | 2008-12-11 | GANT, Thomas, G.; SARSHAR, Sepehr |
Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. |
||||||
44 | METHOD OF PRODUCING ALKOXYLATED ETHER AMINES AND USES THEREOF | EP22881711.0 | 2022-10-12 | EP4416129A1 | 2024-08-21 | DELUGE, Maxence M.; LEWIS, David C. |
A process for preparing alkoxylated ether amines including performing an alkoxylation reaction between a Guerbet alcohol and an epoxide in the presence of a catalyst to obtain an alkoxylated alcohol. Performing an amination reaction on the alkoxylated alcohol in the presence of ammonia and hydrogen to form an alkoxylated Guerbet amine. | ||||||
45 | HYDROPHILIC POLYETHER AMINE SOLUTION AND USES THEREOF | EP22799554.5 | 2022-05-05 | EP4334374A1 | 2024-03-13 | ZHAO, Haibo |
System Solutions and methods for cleaning the air intake valve of a GDI engine during engine operation with a PEA-water solution injection. | ||||||
46 | SURFACTANT COMPOUNDS AND AGROCHEMICAL COMPOSITIONS | EP04736668.7 | 2004-06-11 | EP1643834B1 | 2007-08-01 | BEVINAKATTI, Hanamanthsa Shankarsa |
Compounds of the formula: Rl R2N-CH2-CHO[(AO)m1 R4]-CH2-OR3 where Rl is alkoxylated polyhydroxy hydrocarbyl; R2 is as defined for Rl, or hydrocarbyl, particularly alkyl or alkoxyalkyl, alkoxylated hydroxyalkyl, or a group: -CH2-CHO[(AO)ml R4]-CH2-OR3; R3 is hydrocarbyl; AO is alkyleneoxy; ml is from 0 to 50; such that the average total number of alkyleneoxy groups in the molecule is from 3 to 50; and R4 is hydrogen, or alkyl, are useful as agrochemical adjuvants. The agrochemical can be a plant growth regulator, herbicide, and/or pesticide, for example insecticide, fungicide, acaricide, nematocide, miticide, rodenticide, bactericide, molluscicide and/or bird repellent. Particularly useful formulations include water soluble herbicide(s), particularly such as glyphosate, glufosinate and paraquat. | ||||||
47 | Anti-inflammatory agents | EP88300163.8 | 1988-01-11 | EP0276065A1 | 1988-07-27 | Bollinger, Nancy Grace; Goodson, Theodore, Jr.; Herron, David Kent |
This invention provides benzene derivatives of the Formula I
|
||||||
48 | METHOD OF PRODUCING ALKOXYLATED ETHER AMINES AND USES THEREOF | PCT/US2022046413 | 2022-10-12 | WO2023064364A1 | 2023-04-20 | DELUGE MAXENCE M; LEWIS DAVID C |
A process for preparing alkoxylated ether amines including performing an alkoxylation reaction between a Guerbet alcohol and an epoxide in the presence of a catalyst to obtain an alkoxylated alcohol. Performing an amination reaction on the alkoxylated alcohol in the presence of ammonia and hydrogen to form an alkoxylated Guerbet amine. | ||||||
49 | AMINO-COMBRETASTATIN DERIVATIVE AND USE THEREOF | PCT/CN2021128275 | 2021-11-02 | WO2022100487A1 | 2022-05-19 | WANG JIANPING |
Disclosed is an amino-combretastatin derivative, and in particular a compound represented by general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a hydrate of the pharmaceutically acceptable salt thereof, a solvate thereof or a solvate of the pharmaceutically acceptable salt thereof, and an isomer thereof. In general formula (I), R1 is selected from a C1-C3 alkyl or a C1-C3 haloalkyl, and R2 and R3 are respectively and independently selected from a C1-C6 alkyl, a C1-C6 haloalkyl or a C1-C6 alcohol group. The present invention also relates to the use of such compounds in the preparation of drugs for the treatment of diseases caused by abnormal neovascularization, and tubulin aggregation inhibitors. | ||||||
50 | SUBSTITUTED PHENETHYLAMINES | PCT/US2008065627 | 2008-06-03 | WO2008151179A3 | 2009-03-26 | GANT THOMAS G; SARSHAR SEPEHR |
Disclosed herein are substituted phenethylamine alpha adrenergic receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof. | ||||||
51 | HIGH PURITY (1R,2S,4R)-(-)-2-[(2'-{N,N-DIMETHYLAMINO}-ETHOXY)]-2-[PHENYL]-1,7,7-TRI-[METHYL]-BICYCLO[2.2.1]HEPTANE AND PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF, PROCESS FOR THE PREPARATION OF THESE COMPOUNDS AND MEDICAMENTS CONTAINING THEM | PCT/HU0000044 | 2000-05-10 | WO0068183A3 | 2001-07-26 | LUKACS GYULA; SIMIG GYULA; MEZEI TIBOR; BUDAI ZOLTAN; PORCS-MAKKAY MARTA; KRASZNAI GYOERGY; NAGY KALMAN; VERECZKEYNE DONATH GYOERGYI; SZABO TIBOR; NEMETH NORBERT; SZULAGYI JANOS |
The invention relates to high purity (1R,2S,4R)-(-)-2- [(2'-{N,N- dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri-[methyl] -bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof containing not more than 0.2 % of (1R,3S,4R)-3- [(2'-{N,N- dimethylamino} -ethyl)]-1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane-2-one and/or of a pharmaceutically acceptable acid addition salt thereof. Furthermore the invention is concerned with a process for the preparation of these compounds. Moreover the invention relates to medicaments containing 1 or more of these compounds and their use. | ||||||
52 | 폴리아민 화합물의 제조 방법 및 그의 응용 | KR1020217027248 | 2021-02-05 | KR1020210111322A | 2021-09-10 | |
53 | 비수 용매 내 4차 암모늄 히드록사이드의 색 억제제 | KR1020157019935 | 2014-01-10 | KR101727555B1 | 2017-04-17 | 엥겔,팀; 반리에,알프레드 |
비수용매내 4차오늄히드록사이드; 및이미다졸리딘-2,4-디온을포함하고, 4차암모늄히드록사이드는조성물의약 5중량% 내지약 50중량%의농도를가지며, 이미다졸리딘-2,4-디온은조성물의약 10 내지약 5000 백만분율의농도를가지는, 조성물. | ||||||
54 | 비수 용매 내 4차 암모늄 히드록사이드의 색 억제제 | KR1020157019935 | 2014-01-10 | KR1020150103083A | 2015-09-09 | 엥겔,팀; 반리에,알프레드 |
비수 용매 내 4차 오늄 히드록사이드; 및 이미다졸리딘-2,4-디온을 포함하고, 4차 암모늄 히드록사이드는 조성물의 약 5중량% 내지 약 50중량%의 농도를 가지며, 이미다졸리딘-2,4-디온은 조성물의 약 10 내지 약 5000 백만분율의 농도를 가지는, 조성물.
|
||||||
55 | LUBRICATING OIL ADDITIVE, LUBRICATING OIL ADDITIVE COMPOSITION, AND LUBRICATING OIL COMPOSITION CONTAINING THESE | EP20769802.8 | 2020-03-10 | EP3940045B1 | 2024-12-25 | ODA, Kazuhiro; SHIMIZU, Yutaro; KAWAMOTO, Hideki |
A lubricant additive includes a monoester carboxylic acid salt (A) represented by formula (1).In formula (1), R1 represents a single bond between carbon atoms of carbonyl groups, or a divalent hydrocarbon group having 1 to 4 carbon atoms, and R2 represents a hydrocarbon group having 1 to 22 carbon atoms. AO represents an oxyalkylene group of one type selected from oxyalkylene groups having 2 to 4 carbon atoms, or a mixed oxyalkylene group of two or more types selected from oxyalkylene groups having 2 to 4 carbon atoms, and n is an average number of added moles of the oxyalkylene group represented by AO and is 0 to 5. M represents organic ammonium. | ||||||
56 | AMINO-COMBRETASTATIN DERIVATIVE AND USE THEREOF | EP21891014.9 | 2021-11-02 | EP4245750A1 | 2023-09-20 | WANG, Jianping |
Disclosed is an amino-combretastatin derivative, and in particular a compound represented by general formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof, or a hydrate of the pharmaceutically acceptable salt thereof, a solvate thereof or a solvate of the pharmaceutically acceptable salt thereof, and an isomer thereof. In general formula (I),
|
||||||
57 | LUBRICATING OIL ADDITIVE, LUBRICATING OIL ADDITIVE COMPOSITION, AND LUBRICATING OIL COMPOSITION CONTAINING THESE | EP20769802.8 | 2020-03-10 | EP3940045A4 | 2022-12-14 | ODA, Kazuhiro; SHIMIZU, Yutaro; KAWAMOTO, Hideki |
A lubricant additive includes a monoester carboxylic acid salt (A) represented by formula (1).In formula (1), R1 represents a single bond between carbon atoms of carbonyl groups, or a divalent hydrocarbon group having 1 to 4 carbon atoms, and R2 represents a hydrocarbon group having 1 to 22 carbon atoms. AO represents an oxyalkylene group of one type selected from oxyalkylene groups having 2 to 4 carbon atoms, or a mixed oxyalkylene group of two or more types selected from oxyalkylene groups having 2 to 4 carbon atoms, and n is an average number of added moles of the oxyalkylene group represented by AO and is 0 to 5. M represents organic ammonium. | ||||||
58 | SURFACTANT COMPOUNDS AND AGROCHEMICAL COMPOSITIONS | EP04736668.7 | 2004-06-11 | EP1643834A1 | 2006-04-12 | BEVINAKATTI, Hanamanthsa Shankarsa |
Compounds of the formula: Rl R2N-CH2-CHO[(AO)m1 R4]-CH2-OR3 where Rl is alkoxylated polyhydroxy hydrocarbyl; R2 is as defined for Rl, or hydrocarbyl, particularly alkyl or alkoxyalkyl, alkoxylated hydroxyalkyl, or a group: -CH2-CHO[(AO)ml R4]-CH2-OR3; R3 is hydrocarbyl; AO is alkyleneoxy; ml is from 0 to 50; such that the average total number of alkyleneoxy groups in the molecule is from 3 to 50; and R4 is hydrogen, or alkyl, are useful as agrochemical adjuvants. The agrochemical can be a plant growth regulator, herbicide, and/or pesticide, for example insecticide, fungicide, acaricide, nematocide, miticide, rodenticide, bactericide, molluscicide and/or bird repellent. Particularly useful formulations include water soluble herbicide(s), particularly such as glyphosate, glufosinate and paraquat. | ||||||
59 | Process for preparing (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof | EP00110122.9 | 2000-05-10 | EP1052243A2 | 2000-11-15 | Lukacs, Gyula; Simig, Gyula; Mezei, Tibor; Budai, Zoltan; Porcs-Makkay, Marta; Krasznai, Gyorgy; Nagy, Kalman; Vereczkey, Gyorgyi Donath; Szabo, Tibor; Nemeth, Norbert; Szulagyi, Janos |
The invention relates to a process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2--[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof with higher yields and higher grades of purity. |
||||||
60 | Process for manufacture of N-(polyoxyalkyl)-N-(alkyl)amines | EP89105623.6 | 1989-03-30 | EP0335393A1 | 1989-10-04 | Gerkin, Richard Michael; Cowherd, Frank Garnett; Schreck, David James; Kirchner, David Lee |
A process for the manufacture of N-(polyoxyalkyl)-N-(alkyl)amines is provided by reacting an alcohol with a secondary amine. |